ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,092,000 | – | 41,208 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 3,133,234 | $124,076,000 | 82.43% |
| Deer VII & Co. Ltd. | 1,105,964 | $39,417,000 | 9.51% |
| Foresite Capital Management I, LLC | 66,000 | $2,614,000 | 2.54% |
| QVT Financial LP | 556,574 | $21,592,000 | 1.27% |
| Orbimed Advisors | 2,117,648 | $83,859,000 | 1.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $1,980,000 | 0.55% |
| WALL STREET ASSOCIATES | 93,800 | $3,714,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 197,219 | $7,810,000 | 0.28% |
| EAM Investors, LLC | 37,871 | $1,500,000 | 0.27% |
| Granite Point Capital Management, L.P. | 30,000 | $1,188,000 | 0.20% |